| |
||||||||||||||||||||||
| SPRING - SUMMER 2001 | ||||||||||||||||||||||
Research UpdatesMacular Degeneration (AMD) — WET Positive results from a pilot study completed at The New England Eye Center at Tufts University has paved the way for a large, multi-center clinical trial for the new, experimental laser treatment for Wet AMD — Transpupillary Thermotherapy (TTT). Preliminary research has indicated that TTT may be the best suited treatment for a form of Wet AMD, called occult choroidal neovascularization (occult CNV), where blood vessel growth is hidden. When it is hidden, patients are not likely candidates for photo-dynamic therapy or high-intensity laser treatment. TTT uses a low-intensity laser that seems able to treat hidden blood vessel growth by applying heat to the retina. This slightly raises the temperature of the retina to clot blood within these abnormal blood vessels. The blood clots seal the blood vessels, thus preventing any further leakage and subsequent damage to central vision. Clinical trials are being conducted in various states, among them Minnesota, Ohio and Wisconsin. Macular Degeneration (AMD) — DRY
The Visionary , published as a service of the Illinois Society for the Prevention of Blindness,is available upon request. The information contained in this issue, taken from sources considered to be accurate, does not replace the need for professional eye care consultations and treatments.
|
||||||||||||||||||||||
|
© Copyright 2001 - 2006 Illinois Society for the Prevention of Blindness |
||||||||||||||||||||||